Johnson & Johnson (JNJ)
255.56
+2.28
(+0.90%)
USD |
NYSE |
Oct 16, 16:00
255.26
-0.30
(-0.12%)
After-Hours: 20:00
Johnson & Johnson Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.11B |
| March 31, 2026 | -1.04B |
| December 31, 2025 | -4.485B |
| September 30, 2025 | -542.00M |
| June 30, 2025 | -18.26B |
| March 31, 2025 | -297.00M |
| December 31, 2024 | -1.32B |
| September 30, 2024 | -3.128B |
| June 30, 2024 | -13.69B |
| March 31, 2024 | -464.00M |
| December 31, 2023 | -1.202B |
| September 30, 2023 | 2.541B |
| June 30, 2023 | -3.776B |
| March 31, 2023 | 3.315B |
| December 31, 2022 | -4.397B |
| September 30, 2022 | -1.701B |
| June 30, 2022 | -2.639B |
| March 31, 2022 | -3.634B |
| December 31, 2021 | -5.36B |
| September 30, 2021 | -2.719B |
| June 30, 2021 | -419.00M |
| March 31, 2021 | -185.00M |
| December 31, 2020 | -7.903B |
| September 30, 2020 | -4.819B |
| June 30, 2020 | -7.522B |
| Date | Value |
|---|---|
| March 31, 2020 | -581.00M |
| December 31, 2019 | -1.344B |
| September 30, 2019 | -1.645B |
| June 30, 2019 | -1.788B |
| March 31, 2019 | -1.417B |
| December 31, 2018 | 2.228B |
| September 30, 2018 | -4.269B |
| June 30, 2018 | -201.00M |
| March 31, 2018 | -925.00M |
| December 31, 2017 | -505.00M |
| September 30, 2017 | -1.18B |
| June 30, 2017 | -12.25B |
| March 31, 2017 | -936.00M |
| December 31, 2016 | -2.174B |
| September 30, 2016 | -2.372B |
| June 30, 2016 | 1.322B |
| March 31, 2016 | -1.537B |
| December 31, 2015 | -1.391B |
| September 30, 2015 | -1.001B |
| June 30, 2015 | -3.554B |
| March 31, 2015 | -1.789B |
| December 31, 2014 | -2.922B |
| September 30, 2014 | 735.00M |
| June 30, 2014 | -8.092B |
| March 31, 2014 | -2.026B |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -15.40B |
| Merck & Co., Inc. | -5.602B |
| Pfizer Inc. | 2.106B |
| Bristol Myers Squibb Co. | -1.614B |
| Liquidia Corp. | -12.24M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 22.61B |
| Free Cash Flow Per Share (Quarterly) | 2.990 |
| Free Cash Flow to Equity (Quarterly) | 13.25B |
| Free Cash Flow to Firm (Quarterly) | 7.593B |
| Free Cash Flow Yield | 3.62% |